Page 81 - Michael Erman News Today

Search Exclusive: South Korea in talks with mRNA vaccine makers to make up to 1 billion doses -government official FILE PHOTO: South Korean senior citizens receive their first dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination centre in Seoul, South Korea April 1, 2021. Chung Sung-Jun/Pool via REUTERS reuters_tickers This content was published on July 5, 2021 - 09:27 July 5, 2021 - 09:27 By Sangmi Cha SEOUL (Reuters) - South Korea is in talks with mRNA vaccine m...

Sangmi Cha 6 minute read SEOUL, July 5 (Reuters) - South Korea is in talks with mRNA vaccine makers including Pfizer (PFE.N) and Moderna (MRNA.O) to produce COVID-19 shots in the country and is ready to offer the capacity to make up to 1 billion doses immediately, a senior government official said. The plan, if agreed, would help ease tight global supply of COVID-19 vaccines, particularly in Asia which lags North America and Europe in vaccine rollouts, and put South Korea a step closer to its a...

By Syndicated Content By Sangmi Cha SEOUL (Reuters) – South Korea is in talks with mRNA vaccine makers including Pfizer and Moderna to produce COVID-19 shots in the country and is ready to offer the capacity to make up to 1 billion doses immediately, a senior government official said. The plan, if agreed, would help ease tight global supply of COVID-19 vaccines, particularly in Asia which lags North America and Europe in vaccine rollouts, and put South Korea a step closer to it...

Exclusive: South Korea in talks with mRNA vaccine makers to make up to 1 billion doses -government official Reuters 11 hrs ago By Sangmi Cha SEOUL (Reuters) - South Korea is in talks with mRNA vaccine makers including Pfizer and Moderna to produce COVID-19 shots in the country and is ready to offer the capacity to make up to 1 billion doses immediately, a senior government official said. The plan, if agreed, would help ease tight global supply of COVID-19 vaccines, particularly in Asia whic...

Infectious disease experts are weighing the need for booster shots of the Pfizer/BioNTech (PFE.N), or Moderna (MRNA.O) mRNA-based vaccines for Americans who received Johnson & Johnson's (JNJ.N) one-dose vaccine due to the increasing prevalence of the more contagious Delta coronavirus variant.

Europe's medicines regulator said on Friday it had approved the production of Johnson & Johnson's single-dose COVID-19 vaccine at an additional site in Italy, as it looks to speed up the supply of the shot in the European Union.

The U.S. Food & Drug Administration on Friday said Johnson & Johnson must throw away millions of doses of its COVID-19 vaccine that were manufactured at a…

Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that several other batches were not suitable for use and that others were being evaluated.

Article content The U.S. Food & Drug Administration on Friday said Johnson & Johnson must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use. Two sources familiar with the situation told Reuters that the agency had cleared about 10 million doses. The New York Times said that the batches being discarded amount to around 60 million doses, citing people familiar with the matter. We apologize, but this...

Preliminary findings from two vaccine safety monitoring systems suggest a higher-than-expected number of cases of heart inflammation after the second dose of mRNA COVID-19 vaccines in young men, the U.S. Centers for Disease Control and Prevention said on Thursday.